SIMMS CHRISTOPHER PAUL (Senior Vice President, CCO) sold 6.8% of their position (2.37K shares) of IVERIC BIO, INC. on the open market
Open‑market sale worth $47.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/4/2023ACC: 0001410939-23-000006
Officer· Senior Vice President, CCO
Since Aug 2021
-2.37K
Net shares
Net seller
$47.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
21.9%
1/2/2023
28.55K→34.80K
Common Stock
Direct
Shares
−2.37K
Price / share
$20.06
Trade value
$47.50K
% of position
6.8%
1/3/2023
34.80K→32.43K
Total
Net shares
+3.88K
Net value
-$47.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2023 | M · Option Exercise | +6.25K | — | — | 21.9% | 28.55K | 34.80K |
| Common Stock Direct | 1/3/2023 | S · Sale | −2.37K | $20.06 | $47.50K | 6.8% | 34.80K | 32.43K |
| Total | +3.88K | -$47.50K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
18.75K
Exercisable
—
1/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.25K shares | 1/2/2023 | M · Option Exercise | −6.25K | — | 18.75K |